| abstract |
The present invention relates to methods and drugs for ameliorating insulin resistance in skeletal muscle, a major contributing abnormality to impaired glucose handling in such diseases as type 1 and type 2 diabetes, hypertension, obesity and critical care patients. This invention provides drugs, methods for screening those drugs and methods specifically targeted to ameliorating insulin resistance by increasing capillary blood flow in muscle. |